01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2019–FY2025. Drag across the bars to change the range.
- $19.70B
YoY changeLargest recent move+10.4%in FY17Latest −0.7%
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $19.70B | −0.7% | 10-K | |
| FY2024 | $19.84B | +8.7% | 10-K | |
| FY2023 | $18.25B | −7.6% | 10-K | |
| FY2022 | $19.76B | −2.1% | 10-K | |
| FY2021 | $20.19B | +1.4% | 10-K | |
| FY2019 | $19.92B | +7.5% | 10-K | |
| FY2018 | $18.53B | +4.2% | 10-K | |
| FY2017 | $17.78B | +10.4% | 10-K | |
| FY2016 | $16.11B | +7.4% | 10-K | |
| FY2014 | $15.00B | +8.5% | 10-K | |
| FY2013 | $13.82B | +10.9% | 10-K | |
| FY2012 | $12.46B | −11.0% | 10-K | |
| FY2011 | $14.00B | −1.4% | 10-K | |
| FY2010 | $14.21B | +19.3% | 10-K | |
| FY2008 | $11.91B | −1.4% | 10-K | |
| FY2007 | $12.08B | — | 10-K |
03—Questions
What is JOHNSON & JOHNSON's current free cash flow?
JOHNSON & JOHNSON (JNJ) annual free cash flow for 2025 was $19.70B, a 0.73% decline from 2024. JOHNSON & JOHNSON free cash flow for the quarter ending June 28, 2026 was $7.29B.
What was JOHNSON & JOHNSON's free cash flow in 2024?
JOHNSON & JOHNSON annual free cash flow for 2024 was $19.84B, a 8.74% increase from 2023.
What was JOHNSON & JOHNSON's free cash flow in 2023?
JOHNSON & JOHNSON annual free cash flow for 2023 was $18.25B, a 7.64% decline from 2022.
What is JOHNSON & JOHNSON's 4-year free cash flow CAGR?
JOHNSON & JOHNSON free cash flow grew at a compound annual growth rate (CAGR) of 0.61% from FY2021 to FY2025, going from $20.19B to $19.70B over 4 years.
- Company
- JOHNSON & JOHNSON
- Ticker
- JNJ
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations